Baker Bros. Advisors as of Dec. 31, 2010
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 56 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alere | 12.7 | $70M | 1.9M | 36.60 | |
| Ardea Biosciences | 8.5 | $47M | 5.6M | 8.29 | |
| Genomic Health | 8.0 | $44M | 6.7M | 6.49 | |
| Halozyme Therapeutics (HALO) | 5.7 | $31M | 3.9M | 7.92 | |
| Pharmasset | 5.5 | $30M | 693k | 43.56 | |
| BioCryst Pharmaceuticals (BCRX) | 5.2 | $29M | 5.6M | 5.17 | |
| Salix Pharmaceuticals | 4.9 | $27M | 570k | 46.96 | |
| Auxilium | 4.7 | $26M | 6.0M | 4.33 | |
| Ym Biosciences | 3.9 | $21M | 9.1M | 2.33 | |
| Micromet | 3.8 | $21M | 2.5M | 8.12 | |
| Dendreon Corporation | 3.2 | $18M | 506k | 34.92 | |
| Inspire Pharmaceuticals | 3.1 | $17M | 2.0M | 8.40 | |
| Acorda Therapeutics | 2.5 | $14M | 508k | 27.26 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $14M | 505k | 26.93 | |
| Pharmacyclics | 2.2 | $12M | 2.0M | 6.08 | |
| InterMune | 1.7 | $9.1M | 249k | 36.40 | |
| Trimeris | 1.6 | $8.5M | 3.5M | 2.46 | |
| Adolor Corporation (ADLR) | 1.5 | $8.4M | 6.9M | 1.21 | |
| Medivation | 1.4 | $7.6M | 500k | 15.17 | |
| Chelsea Therapeutics International | 1.3 | $7.2M | 965k | 7.50 | |
| Human Genome cv 2.25% | 1.3 | $7.2M | 4.5M | 1.60 | |
| XenoPort | 1.2 | $6.8M | 800k | 8.52 | |
| Anacor Pharmaceuticals In | 1.2 | $6.4M | 1.2M | 5.37 | |
| Amylin Pharmaceuticals Inc note 2.500% 4/1 | 1.1 | $6.3M | 6.3M | 1.00 | |
| Achillion Pharmaceuticals | 1.1 | $6.1M | 1.5M | 4.15 | |
| Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.0 | $5.7M | 3.9M | 1.45 | |
| Amicus Therapeutics (FOLD) | 1.0 | $5.5M | 1.2M | 4.70 | |
| ZIOPHARM Oncology | 0.9 | $4.9M | 1.0M | 4.66 | |
| GTx | 0.8 | $4.6M | 1.7M | 2.65 | |
| Threshold Pharma | 0.8 | $4.2M | 3.1M | 1.35 | |
| Exelixis (EXEL) | 0.8 | $4.1M | 500k | 8.21 | |
| Anthera Pharmaceuticals | 0.7 | $3.9M | 800k | 4.88 | |
| Alere Inc note 3.000% 5/1 | 0.7 | $3.7M | 3.5M | 1.06 | |
| A.P. Pharma (APPA) | 0.6 | $3.1M | 6.9M | 0.45 | |
| Inhibitex | 0.4 | $2.3M | 872k | 2.60 | |
| AVANIR Pharmaceuticals | 0.4 | $2.0M | 500k | 4.08 | |
| Cypress Bioscience (CYPB) | 0.3 | $1.9M | 300k | 6.48 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $1.2M | 199k | 5.93 | |
| DepoMed | 0.2 | $1.2M | 183k | 6.36 | |
| Amylin Pharmaceuticals | 0.2 | $1.1M | 76k | 14.71 | |
| Lexicon Pharmaceuticals | 0.2 | $1.1M | 750k | 1.44 | |
| Bristol Myers Squibb (BMY) | 0.2 | $1.1M | 40k | 26.48 | |
| Idera Pharmaceuticals | 0.1 | $834k | 288k | 2.89 | |
| Ligand Pharmaceuticals | 0.1 | $746k | 84k | 8.92 | |
| Cornerstone Biopharma | 0.1 | $650k | 112k | 5.79 | |
| Cumberland Pharmaceuticals (CPIX) | 0.1 | $577k | 96k | 5.99 | |
| Anadys Pharmaceuticals (ANDS) | 0.1 | $343k | 241k | 1.42 | |
| Cadence Pharmaceuticals | 0.1 | $292k | 39k | 7.54 | |
| Sucampo Pharmaceuticals | 0.1 | $247k | 64k | 3.84 | |
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $211k | 176k | 1.20 | |
| Pozen | 0.0 | $142k | 21k | 6.64 | |
| Alere | 0.0 | $183k | 732.00 | 250.00 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $85k | 22k | 3.80 | |
| AutoImmune (AIMM) | 0.0 | $7.0k | 13k | 0.54 | |
| Aradigm Corporation (ARDM) | 0.0 | $17k | 100k | 0.17 | |
| VIA Pharmaceuticals (VIAP) | 0.0 | $4.1k | 103k | 0.04 |
